1 Saji S., "Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer" 24 : 4531-4539, 2005
2 Martin-Lluesma S, "Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2" 297 : 2267-2270, 2002
3 Lewis JS, "Regulation of cell cycle and cyclins by 16α- hydroxyestrone in MCF-7 breast cancer cells" 27 : 293-307, 2001
4 Rozen S, "Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz S and Misener S" Humana Press 365-386, 2000
5 Ernst M., "Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo" 33 : 907-914, 1989
6 Seong Hwan Kim, "Mitogenic Estrogen Metabolites Alter the Expression of 17β-estradiol-regulated Proteins Including Heat Shock Proteins in Human MCF-7 Breast Cancer Cells" 한국분자세포생물학회 20 (20): 378-384, 2005
7 DeLuca JG., "Kinetochore microtubule dynamics and attachment stability are regulated by Hec1" 127 : 969-982, 2006
8 Banerjee A,, "Increased levels of tyrosinated α-, β(III)-, and β(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells" 293 : 598-601, 2002
9 Fishman J., "Increased estrogen-16 a-hydroxylase activity in women with breast and endometrial cancer" 20 : 1077-1081, 1984
10 Lee EA, "Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells" 3 : 661-669, 2004
1 Saji S., "Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer" 24 : 4531-4539, 2005
2 Martin-Lluesma S, "Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2" 297 : 2267-2270, 2002
3 Lewis JS, "Regulation of cell cycle and cyclins by 16α- hydroxyestrone in MCF-7 breast cancer cells" 27 : 293-307, 2001
4 Rozen S, "Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz S and Misener S" Humana Press 365-386, 2000
5 Ernst M., "Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo" 33 : 907-914, 1989
6 Seong Hwan Kim, "Mitogenic Estrogen Metabolites Alter the Expression of 17β-estradiol-regulated Proteins Including Heat Shock Proteins in Human MCF-7 Breast Cancer Cells" 한국분자세포생물학회 20 (20): 378-384, 2005
7 DeLuca JG., "Kinetochore microtubule dynamics and attachment stability are regulated by Hec1" 127 : 969-982, 2006
8 Banerjee A,, "Increased levels of tyrosinated α-, β(III)-, and β(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells" 293 : 598-601, 2002
9 Fishman J., "Increased estrogen-16 a-hydroxylase activity in women with breast and endometrial cancer" 20 : 1077-1081, 1984
10 Lee EA, "Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells" 3 : 661-669, 2004
11 Hwang K.C., "Identification of differentially regulated genes in bovine blastocysts using an annealing control primer system" 69 : 43-51, 2004
12 Ryu JY, "Identification of differentially expressed genes in the testis of Sprague-Dawley rats treated with di(n-butyl) phthalate" 234 : 103-112, 2007
13 Delmas PD., "Hormone replacement therapy in the prevention and treatment of osteoporosis" 1 : S3-7, 1997
14 Grady D., "HERS Research Group (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (HERS II)" Heart and estrogen/progestin replacement study follow-up(HERS II).JAMA 288,49-57. 288 : 49-57, 2002
15 Gupta M., "Estrogenic and antiestrogenic activities of 16α- and 2-hydroxy metabolites of 17β-estradiol in MCF-7 and T47D human breast cancer cells" 67 : 413-419, 1998
16 Clemons M., "Estrogen and the risk of breast cancer" 344 : 276-285, 2001
17 Darbre P., "Effect of estradiol on human breast cancer cells in culture" 43 : 349-354, 1983
18 Sengupta S., "Drug target interaction of tubulin-binding drugs in cancer therapy" 6 : 1433-1447, 2006
19 Li L, "Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells" 14 : 817-824, 2007
20 Swaneck GE, "Covalent binding of the endogenous estrogen 16 a-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization" 85 : 7831-7835, 1988
21 Fishman J., "Biological properties of 16 a-hydroxyestrone: implications in estrogen physiology and pathophysiology" 51 : 611-615, 1980
22 Kim YJ, "Annealing control primer system for identification of differentially expressed genes on agarose gels" 36 : 424-430, 2004
23 Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method" 25 : 402-408, 2001
24 Hayama S., "Activation of CDCA1-KNTC2, members of centromere protein complex" 66 : 10339-10348, 2006
25 Schneider J., "Abnormal oxidative metabolism of estradiol in women with breast cancer" 79 : 3047-3051, 1982
26 McGuire WL, "A physiological role for estrogen and progesterone in breast cancer" 7 : 875-882, 1976